Medpace Holdings IncMEDP
Price$598.08Intrinsic value$509.5215% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.8B+31.9% YoYTTM through 30 Jun 2026
Net Income $491.5M+21.5% YoYTTM through 30 Jun 2026
Free Cash Flow $706.7MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin22.0%
Operating Margin20.0%
Net Margin17.7%

Returns

113.3%ROE
23.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio0.85x
Net Debt-$652.7Mnet cash position
Cash & Equivalents$502.7M

Quality Metrics

Altman Z-Score8.22
Piotroski F-Score6 / 9
FCF Margin25.4%
Rule of 4027.9
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.5B
Diluted EPS$17.02TTM
'19'20'21'22'23'24'25
FY2025: $15.28

Dividend

No dividend

Capital Allocation

Capex Intensity1.7%

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.